Families with transgender adolescents enrolled in Medicaid in New Hampshire filed a federal lawsuit in October 2026, challenging a Centers for Medicare & Medicaid Services rule that blocks federal funding for pediatric gender-affirming care. The litigation tests the administration’s authority under the Administrative Procedure Act and the Fifth Amendment.
The federal policy directly impacts funding streams across state-administered healthcare programs, creating immediate compliance and reimbursement hurdles for pediatric care providers.
The Bottom Line
- Funding Restrictions: The CMS rule explicitly terminates federal Medicaid and CHIP matching funds for pediatric gender-affirming procedures.
- Legal Vulnerability: Plaintiffs argue the mandate violates the Administrative Procedure Act, drawing parallels to recent judicial pushback against Department of Health and Human Services directives.
- Constitutional Claims: The New Hampshire lawsuit introduces a Fifth Amendment equal protection challenge, alleging the regulation stems from discriminatory animus.
Administrative Procedure Act Challenges After Loper Bright
The legal framework governing federal healthcare oversight has shifted significantly. According to reporting by AJMC, the plaintiffs’ arguments under the Administrative Procedure Act gain substantial weight following the Supreme Court’s decision in Loper Bright, which curtails judicial deference to federal agency interpretations.
The New Hampshire filing mirrors broader legal friction encountered by the administration. In April, a federal district court in Oregon vacated a directive issued by HHS Secretary Robert F. Kennedy Jr. seeking to bar medical professionals providing pediatric gender-affirming treatments from participating in federal healthcare programs. The presiding court determined that the Kennedy announcement bypassed mandatory notice-and-comment procedures, overstepped the statutory powers granted to HHS, and encroached upon state authority.
While the finalized Medicaid rule did proceed through notice-and-comment rulemaking—unlike the Kennedy declaration—legal analysts suggest that overlapping judicial skepticism could hamper the administration’s defense.
Parallel Rulings and Essential Health Benefits Precedent
The timing of concurrent judicial decisions has intensified the scrutiny facing federal health mandates. A ruling by the US District Court for the District of Massachusetts vacated an essential health benefits exclusion just one day after the Medicaid rule was published.
During discussions analyzed by AJMC, legal experts noted that while the Massachusetts case relied on specific statutory processes within the Affordable Care Act that do not directly apply to the Medicaid rule, the cumulative judicial trend signals an uphill battle for federal defenders in ongoing litigation.
| Legal Challenge | Jurisdiction | Primary Legal Ground | Current Status |
|---|---|---|---|
| New Hampshire Medicaid Suit | Federal District Court | APA & Fifth Amendment Equal Protection | Active Litigation (October 2026) |
| California v. Kennedy Declaration | US District Court for Oregon | Notice-and-Comment & Statutory Authority | Vacated in April |
| Essential Health Benefits Exclusion | US District Court for Massachusetts | ACA Revision Process Violations | Vacated |
Congressional Scrutiny and Enforcement Actions
Beyond courtroom battles, the regulatory squeeze on pediatric gender care involves multiple federal agencies. The Department of Justice and the HHS Office of Inspector General continue active enforcement and provider referrals, maintaining pressure regardless of pending administrative petitions or comments on proposed rules like the hospital Conditions of Participation.
Observers indicate that further policy shifts depend heavily on upcoming midterm election outcomes. Should congressional majorities pivot, legislative action could directly target the statutory funding bans currently locked in federal courts.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
